Wen‐Ping Lin

584 total citations
30 papers, 388 citations indexed

About

Wen‐Ping Lin is a scholar working on Oncology, Hepatology and Molecular Biology. According to data from OpenAlex, Wen‐Ping Lin has authored 30 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Wen‐Ping Lin's work include Cancer Immunotherapy and Biomarkers (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Wen‐Ping Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Wen‐Ping Lin collaborates with scholars based in China, Democratic Republic of the Congo and Chile. Wen‐Ping Lin's co-authors include Jie Mei, Rong Guo, Lianghe Lu, Shaohua Li, Xuqi Sun, Jingwen Zou, Wei Wei, Zhi‐Jun Sun, Minshan Chen and Hao Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wen‐Ping Lin

26 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Ping Lin China 13 196 185 91 90 65 30 388
Claudia Angela Maria Fulgenzi United Kingdom 12 226 1.2× 166 0.9× 63 0.7× 85 0.9× 82 1.3× 47 416
Ziyu Xun China 11 175 0.9× 112 0.6× 55 0.6× 94 1.0× 72 1.1× 35 340
Ruocai Xu China 7 131 0.7× 242 1.3× 71 0.8× 55 0.6× 63 1.0× 11 349
Chenhe Yi China 8 157 0.8× 111 0.6× 81 0.9× 63 0.7× 119 1.8× 16 354
Joseph Tang United Kingdom 8 177 0.9× 134 0.7× 64 0.7× 48 0.5× 54 0.8× 14 322
Nikoletta Sidiropoulos United States 8 163 0.8× 51 0.3× 135 1.5× 114 1.3× 76 1.2× 21 336
Long-Zi Liu China 8 109 0.6× 95 0.5× 81 0.9× 74 0.8× 96 1.5× 8 325
Maria Aurelia Barbera Italy 9 134 0.7× 104 0.6× 53 0.6× 70 0.8× 69 1.1× 19 284
Xiao-Dong Zhu China 10 130 0.7× 90 0.5× 128 1.4× 83 0.9× 155 2.4× 14 375

Countries citing papers authored by Wen‐Ping Lin

Since Specialization
Citations

This map shows the geographic impact of Wen‐Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Ping Lin more than expected).

Fields of papers citing papers by Wen‐Ping Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Ping Lin. The network helps show where Wen‐Ping Lin may publish in the future.

Co-authorship network of co-authors of Wen‐Ping Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Ping Lin. A scholar is included among the top collaborators of Wen‐Ping Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Ping Lin. Wen‐Ping Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Tao, Hao Li, Wen‐Ping Lin, et al.. (2025). Logic-gate nanocompiler for oxidative/reductive molecular parallel detection during hepatic ischemia-reperfusion injury. Chemical Engineering Journal. 519. 164923–164923.
2.
Li, Hao, Mengjie Zhang, Boxin Zhang, et al.. (2025). Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer. Nature Communications. 16(1). 4228–4228. 7 indexed citations
3.
Yin, Yixin, Jinlong Lin, Run‐Cong Nie, et al.. (2025). Phase separation of ERCC6L2–CtIP regulates the extent of DNA end resection. Nature Cell Biology. 27(10). 1771–1784.
4.
5.
Lin, Wen‐Ping, Hao Li, & Zhi‐Jun Sun. (2024). T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle. EBioMedicine. 104. 105154–105154. 17 indexed citations
6.
Lin, Wen‐Ping, Qing Wang, Shuo Wang, et al.. (2024). Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity. Cell Proliferation. 58(1). e13740–e13740. 6 indexed citations
7.
Guan, Renguo, Jie Mei, Wen‐Ping Lin, et al.. (2023). Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?. Hepatology International. 17(5). 1279–1288. 13 indexed citations
8.
Liu, Jie, Wen‐Ping Lin, Wen Su, et al.. (2023). Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC. International Immunopharmacology. 119. 110243–110243. 14 indexed citations
9.
Liu, Jie, Wen‐Ping Lin, Yao Xiao, et al.. (2023). VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma. International Immunopharmacology. 125(Pt A). 111128–111128. 12 indexed citations
10.
Li, Shaohua, Jie Mei, Qiaoxuan Wang, et al.. (2023). Comparison of anti–PD-L1 with anti–PD-1 antibodies in the combination of HAIC and lenvatinib for the treatment of unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. 41(4_suppl). 509–509. 2 indexed citations
11.
Lu, Lianghe, Zhangping He, Run‐Cong Nie, et al.. (2022). C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Frontiers in Immunology. 13. 808101–808101. 29 indexed citations
12.
Yin, Yixin, Yihong Ling, Xiaoli Wei, et al.. (2022). Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients. Frontiers in Immunology. 13. 973085–973085. 18 indexed citations
13.
Guan, Renguo, Wen‐Ping Lin, Jingwen Zou, et al.. (2022). Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma. Cancer Control. 29. 2905520868–2905520868. 14 indexed citations
14.
Mei, Jie, Wen‐Ping Lin, Shaohua Li, et al.. (2022). Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 5–5. 22 indexed citations
15.
Mei, Jie, Shaohua Li, QiJiong Li, et al.. (2021). Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 167–176. 44 indexed citations
16.
Deng, Min, Rongce Zhao, Shaohua Li, et al.. (2021). Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. BMC Cancer. 21(1). 1347–1347. 5 indexed citations
17.
Sun, Xuqi, Jie Mei, Wen‐Ping Lin, et al.. (2021). Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients. BMC Cancer. 21(1). 775–775. 55 indexed citations
18.
Mei, Jie, Wen‐Ping Lin, Feng Shi, et al.. (2021). Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy. European Journal of Radiology. 142. 109890–109890. 10 indexed citations
19.
Zou, Jingwen, Kunpeng Du, Shaohua Li, et al.. (2021). Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis. Genes. 12(9). 1305–1305. 18 indexed citations
20.
Mei, Jie, Shaohua Li, Qiaoxuan Wang, et al.. (2020). Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study. Frontiers in Oncology. 10. 573–573. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Angela Maria Fulgenzi Breakdown of academic impact, for papers by Ziyu Xun Breakdown of academic impact, for papers by Ruocai Xu Breakdown of academic impact, for papers by Chenhe Yi Breakdown of academic impact, for papers by Joseph Tang Breakdown of academic impact, for papers by Nikoletta Sidiropoulos Breakdown of academic impact, for papers by Long-Zi Liu Breakdown of academic impact, for papers by Maria Aurelia Barbera Breakdown of academic impact, for papers by Xiao-Dong Zhu
Rankless by CCL
2026